trump on glp 1 Says Obesity Drugmakers Will Cut GLP-1 Prices—Medicare Will Cover Some Costs Trump says U.S. to provide

Melanotan 2 is not approved by the FDA for any use

A particularly valuable benefit is weight loss , which distinguishes GLP-1 receptor agonists from many other glucose-lowering medicines

Gastroparesis Gastroparesis is a chronic, severe and debilitating disorder that may be associated with dysfunction in the enteric nervous system, causing the movement of food from the stomach to the small intestine to slow or stop, and preventing or disrupting normal digestion

1 2 3 4 5 Vitam Horm

I would be very interested on your take on two things1) the very high discontinuation rate of these drugs (and the corresponding need for a focus on behavior change as an adjuvant/parallel to course of treatment) and, 2) the impact of significant lean muscle and bone loss during treatment w/GLP-1s